Codexis (CDXS) Net Cash Flow Growth (5y) (2015 - 2026)
Codexis (CDXS) Net Cash Flow Growth (5y) (2015 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
719,706.53 Bn |
719,706.50 Bn |
- |
| 2 |
Belite Bio |
55,800.00 Bn |
55,800.00 Bn |
- |
| 3 |
Quantum Biopharma |
18,182.30 Bn |
18,182.29 Bn |
- |
| 4 |
Legend Biotech |
3,154.00 Bn |
3,153.71 Bn |
242.10 Mn |
| 5 |
Akari Therapeutics |
1,844.30 Bn |
1,844.29 Bn |
- |
| 6 |
Evaxion A |
1,567.96 Bn |
1,567.94 Bn |
- |
| 7 |
Psyence Biomedical |
251.43 Bn |
251.42 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
112.56 Bn |
105.31 Bn |
2.59 Bn |
| 9 |
Abivax |
94.37 Bn |
94.37 Bn |
- |
| 10 |
Codexis |
236.00 Mn |
170.86 Mn |
13.18 Mn |
| Date | Value |
|---|
| Mar 31, 2026 |
-9.77% |
| Dec 31, 2025 |
-19.65% |
| Sep 30, 2025 |
19.10% |
| Jun 30, 2025 |
22.18% |
| Mar 31, 2025 |
21.69% |
| Dec 31, 2024 |
-61.57% |
| Sep 30, 2024 |
75.29% |
| Jun 30, 2024 |
-23.36% |
| Mar 31, 2024 |
-5.63% |
| Dec 31, 2023 |
-53.59% |
| Sep 30, 2023 |
-101.17% |
| Jun 30, 2023 |
-18.80% |
| Mar 31, 2023 |
-9.86% |
| Dec 31, 2022 |
-6.53% |
| Sep 30, 2022 |
41.58% |
| Jun 30, 2022 |
-17.92% |
| Mar 31, 2022 |
-33.34% |
| Dec 31, 2021 |
-19.76% |
| Sep 30, 2021 |
-6.78% |
| Jun 30, 2021 |
-123.88% |
